04:37 PM EDT, 03/27/2026 (MT Newswires) -- Martine A Rothblatt, Director, Chairperson & CEO, on March 26, 2026, sold 9,500 shares in United Therapeutics ( UTHR ) for $5,090,216. Following the Form 4 filing with the SEC, Rothblatt has control over a total of 679,872 common shares of the company, with 40,513 shares held directly and 639,359 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1082554/000110657826000021/xslF345X05/primarydocument.xml